FDA: Medtronic brain stimulator missed study goal

WASHINGTON (AP) - The Food and Drug Administration says a Medtronic nerve stimulating implant failed to significantly reduce seizures in epilepsy patients.

By: Associated Press | WNCT-On Your Side
Published: March 10, 2010

» Comments | Post a Comment

WASHINGTON (AP) - The Food and Drug Administration says a Medtronic nerve stimulating implant failed to significantly reduce seizures in epilepsy patients.
Medtronic Inc. has asked the FDA to approve its Deep Brain Stimulation implant for epilepsy, a neurological disease that causes seizures.
The device is already used to treat other movement disorders, including Parkinson's Disease.
In documents posted online, the FDA says Medtronic's device failed to meet its primary study goal, which was a reduction in seizures after three months in patients with the device compared to those without it.
After Medtronic completed the study, the FDA says the company re-analyzed the data to show a significant reduction.
The FDA will ask a panel to weigh those results this Friday.

Reader Comments

*Facebook Account Required to Comment. If you are not already logged into Facebook, please click the comment button to do so.

Deal of the Day

Interactive Radar

Caught On Camera

Hundreds of Marilyn Monroe look-a-likes gather to break world record

A bear and moose take the path less traveled and hundreds of Marilyn Monroe look-a-likes try to break a record. The latest video and stories that will have you talking are coming up now in Take a Look At This!